A Neuroendocrine Tumor of Unknown Primary Origin that Responded to Treatment Based on Tumor Grade Progression

Yukako Hamano1, Toshikazu Moriwaki1, Keii To1

  • 1Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Japan.

Insights

Neuroendocrine tumors (NETs) initially treated with somatostatin analogs (SSAs) can progress to neuroendocrine carcinoma (NEC). Platinum-based chemotherapy effectively treated a patient's NEC after SSA failure, demonstrating a successful treatment shift.

Area of Science:

  • Oncology
  • Medical Research

Background:

  • Standard treatments for neuroendocrine tumors (NETs) include somatostatin analogs (SSAs) for G1/G2 NETs and platinum-based chemotherapy for neuroendocrine carcinoma (NEC).
  • Accurate classification of NETs is crucial for determining appropriate therapeutic strategies.

Observation:

  • A 46-year-old male patient with metastatic NET G2 showed initial stability with SSA treatment for one year.
  • Tumor progression was observed, and a subsequent biopsy revealed a transformation to neuroendocrine carcinoma (NEC).

Findings:

  • The patient received platinum-based chemotherapy (cisplatin plus etoposide) following the NEC diagnosis.
  • Significant tumor size reduction was achieved with the platinum-containing chemotherapy regimen.

Implications:

  • This case highlights the potential for NETs to dedifferentiate into NEC and the efficacy of platinum-based chemotherapy in such advanced cases.
  • It suggests a potential treatment pathway for patients with advanced NETs that progress despite SSA therapy.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.9K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.8K
Graded Potential01:19

Graded Potential

Graded potentials are localized fluctuations in the cell membrane's electrical charge, commonly found in the dendrites of neurons. The magnitude of these potential changes depends on the strength of the initiating stimulus. In a membrane at its resting potential, a graded potential signifies a voltage shift either above -70 mV or below -70 mV.
Graded potentials fall into two categories: depolarizing and hyperpolarizing. Depolarizing graded potentials typically occur when sodium (Na+) or...
7.0K
Testing a Claim about Mean: Unknown Population SD01:21

Testing a Claim about Mean: Unknown Population SD

A complete procedure of testing a hypothesis about a population mean when the population standard deviation is unknown is explained here.
Estimating a population mean requires the samples to be approximately normally distributed. The data should be collected from the randomly selected samples having no sampling bias. There is no specific requirement for sample size. But if the sample size is less than 30, and we don't know the population standard deviation, a different approach is used;...
6.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K